Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

Jean-Pascal Lefaucheur; N. Andre-obadia; A. Antal; S. Ayache; L. Garcia-Larrea

DOI:10.1016/j.clinph.2014.05.021

Corpus ID: 206798663

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

@article{Lefaucheur2014EvidencebasedGO,
  title={Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)},
  author={Jean-Pascal Lefaucheur and N. Andre-obadia and A. Antal and S. Ayache and L. Garcia-Larrea},
  journal={Clinical Neurophysiology},
  year={2014},
  volume={125},
  pages={2150-2206}
}

Jean-Pascal Lefaucheur, N. Andre-obadia, +2 authors L. Garcia-Larrea

Published 2014

Psychology, Medicine

Clinical Neurophysiology

A group of European experts was commissioned to establish guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) from evidence published up until March 2014, regarding pain, movement disorders, stroke, amyotrophic lateral sclerosis, multiple sclerosis, epilepsy, consciousness disorders, tinnitus, depression, anxiety disorders, obsessive-compulsive disorder, schizophrenia, craving/addiction, and conversion. Despite unavoidable inhomogeneities, there is a… CONTINUE READING

View on Elsevier

Share This Paper

1,074 Citations

Highly Influencial Citations

Background Citations

332

Methods Citations

102

Results Citations

Paper Mentions

INTERVENTIONAL CLINICAL TRIAL

Repetitive Transcranial Magnetic Stimulation as Therapy for Apathy in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of central and peripheral motor neurons. ALS leads to death usually within 3 to… Expand

Conditions	Amyotrophic Lateral Sclerosis
Intervention	Device

Jagiellonian University

April 2019 - December 2021

INTERVENTIONAL CLINICAL TRIAL

Repetitive Transcranial Magnetic Stimulation as Therapy for Depression in Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive loss of central and peripheral motor neurons. ALS leads to death usually within 3 to… Expand

Conditions	Amyotrophic Lateral Sclerosis
Intervention	Device

Jagiellonian University

April 2019 - December 2021

INTERVENTIONAL CLINICAL TRIAL

Efficacy and Safety of rTMS Plus Rehabilitation for the Improvement of the Upper Extremity in Stroke (ERES)

The rehabilitation of the upper limb after a stroke is a challenge due to its complexity and the important cerebral representation of it, particularly of the hand. Repetitive… Expand

Conditions	Arm Paralysis, Stroke
Intervention	Device

Institut Guttmann

October 2019 - April 2021

INTERVENTIONAL CLINICAL TRIAL

rTMS and Botulinum Toxin in Primary Cervical Dystonia

Primary cervical dystonia (PCD) is the most common form of focal dystonia. PCD is frequently reported as a source of disability, decreased quality of life, and social stigma. Botulinum… Expand